Skip to content
Beacon

LABUDirexion Daily S&P Biotech Bull 3X Shares

Take a bet11y track recordRanked #62 of 949 in this goal

Seeks daily investment results of 300% of the daily performance of the Index.

By Direxion Funds · Launched 2015

Annual Cost

0.96%

#4,996 of 5,861 · expensive

Fund Size

$678M

#1,381 of 5,861 · large

Return (1Y)Goal

+266.2%

Track Record

11 years

#1,278 of 5,861 · established

Performance

Total-return NAV · USD
Growth of $10,000
$24,485+144.9%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Leveraged

Sector

Health care

Index tracked

S&P Biotechnology Select Industry Index

What it actually holds

By weight

Concentration

synthetic exposure — holdings shown are derivatives collateral, not the fund's positions

DREYFUS GOVERNMENT CASH MANAGE
7.9%
GOLDMAN FINANCIAL
6.7%
N/A
2.8%
GOLDMAN SACHS LIQ ES FD A
1.8%
Apellis Pharmaceuticals Inc
1.5%
N/A
1.5%
Revolution Medicines Inc
1.4%
Travere Therapeutics Inc
1.3%
ARROWHEAD PHARMACEUTICALS INC
1.2%
Twist Bioscience Corporation
1.2%

Asset allocation

Stocks
82.3%
Cash
17.7%

By sector

Healthcare
99.5%
Financial Services
0.5%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
80.3%High

Year-on-year price swings

Max drawdown
-99.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.65Decent risk-adjusted returns
Sortino (3Y)
0.94Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks daily investment results of 300% of the daily performance of the Index.
Strategy
Invests primarily in U.S.-based biotechnology companies with a float-adjusted market capitalization above $300 million, aiming for 3X daily leveraged exposure to the Index. The Fund is non-diversified and rebalances daily to maintain its investment objective.
Inception date
May 28, 2015
Fund family
Direxion Funds

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged
Warning

Your return drifts the longer you hold

Leverage amplifies the index's daily move, by 2x or 3x. The fund resets every day, so over weeks and months your real return drifts from that multiple. It can run ahead in a smooth climb and bleed in a choppy one. Hold one for months and you own a different bet than the label suggests.

Sources: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at LABU. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04